Navigation Links
Neogen acquires Prima Tech
Date:11/1/2013

LANSING, Mich., Nov. 1, 2013 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of Prima Tech Incorporated, a veterinary instrument company based in Kenansville, North Carolina. Started in 1998 by Kim Quinn, Prima Tech has become an important supplier of unique veterinary instruments in the U.S. and major portions of Europe.

The Prima Tech product line is designed around unique and highly accurate devices used by farmers, ranchers, and veterinarians to inject animals, provide topical applications, and to use for oral administration. Prima Tech is also a unique supplier of products used in artificial insemination in the swine industry. Other products include animal identification and handling equipment.

"Our two companies have considered the possibility of combination for several years. As the Prima Tech business continued to grow, that company's management felt the opportunities for continued growth and customer service would be best served through a larger organization such as Neogen," said Dr. Jason Lilly, Neogen's vice president of corporate development. "We plan to leave the manufacturing of the technical instruments with the current staff in the Kenansville, North Carolina plant, and may move some customer service and distribution functions to our Lexington, Kentucky operation, where they can be streamlined with the remainder of our large veterinary instrument business."

Prima Tech has customer relations and international distribution complementary to Neogen's Ideal Instruments product line. The combination of the product lines is expected to improve service to livestock producers.

"We built the Prima Tech business one instrument at a time as we asked customers what they needed, went back and engineered prototypes and later finished products. This continued dependence on the voice of the customer has enabled us to build a very nice veterinary instrument business and a group of long-time loyal customers," said Kim Quinn, Prima Tech owner and founder. "Through those years we always had great respect for Neogen, their products, and their industry reputation. When we felt the business was best joined to a larger firm with more worldwide reach, it was our desire to place our customers and product lines with Neogen."

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACT:

Steven J. Quinlan,


Vice President & CFO


517/372-9200


'/>"/>
SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Corporation Announces 2nd Quarter Results Conference Call
2. Neogen Reports Second Quarter Results
3. Neogen Launches Fully Quantitative Lateral Flow Test for DON
4. Neogen launches the fastest molecular pathogen test
5. Neogen acquires Igenity from Merial
6. Neogen Corporation Announces Year-End Results Conference Call
7. Neogen reports year end results
8. Neogen Corporation Announces 1st Quarter Results Conference Call
9. Neogen reports 30% increase in quarterly net income
10. Neogen Corporation Announces 3rd Quarter Results Conference Call
11. Neogen launches rapid tests for ractopamine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... ... January 11, 2017 , ... ... Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against ... previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... year and costing healthcare systems more than $23.7 billion, healthcare systems are ... , Among the most common sepsis-causing pathogens are bacteria and the yeast ...
(Date:1/11/2017)... ... 11, 2017 , ... Symbios Technologies, Inc., a ... Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) ... the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):